Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025

Core Insights - DarioHealth Corp. has launched five new contracts with self-insured employers, covering 107,000 lives, which reinforces its B2B2C momentum and recurring revenue growth [1][2] - The company's digital health solutions have demonstrated significant results, including a 23% reduction in hospitalizations, a 9% reduction in healthcare utilization, and a $5,000 reduction in employer costs per user [1] - Dario's pipeline of commercial opportunities has increased to $67 million, with expectations to sign approximately 40 new clients by the end of 2025, representing a 35% increase over 2024 [2] Company Overview - DarioHealth Corp. is a leader in the digital health market, focusing on chronic condition management through a user-centric, multi-chronic condition digital therapeutics platform [3] - The platform provides personalized interventions driven by data analytics and coaching for conditions such as diabetes, hypertension, and weight management [3][4] Product Efficacy - Dario's solutions have shown measurable improvements in health outcomes: a 1.4% reduction in eHbA1c for diabetes management, a 10% reduction in BMI for prediabetes, and 38% of users reducing blood pressure by one stage for hypertension [6]